costs, uncertainties, and risks related to engaging in business globally;
•
devaluations in foreign currency exchange rates, changes in interest rates, and inflation or deflation;
•
significant and sudden declines or volatility in the trading price of our common stock and market capitalization;
•
litigation, investigations, or other similar proceedings involving past, current, or future products or activities;
•
changes in tax law and regulation, tax rates, or events that differ from our assumptions related to tax positions;
3
•
regulatory changes and developments;
•
regulatory oversight and actions regarding our operations and products;
•
regulatory compliance problems or government investigations;
•
risks from the proliferation of counterfeit, misbranded, adulterated, or illegally compounded products;
•
actual or perceived deviation from environmental-, social-, or governance-related requirements or expectations;
•
asset impairments and restructuring charges; and
•
changes in accounting and reporting standards.
Investors should also carefully read the factors described under Item 1A, "Risk Factors" in this Annual Report on Form 10-K for a description of certain risks that could, among other things, cause our actual results to differ from those expressed in forward-looking statements. Investors should understand that it is not possible to predict or identify all such factors and should not consider the risks described above and under Item 1A, "Risk Factors" to be a complete statement of all potential risks and uncertainties.
All forward-looking statements speak only as of the date of this Annual Report and are expressly qualified in their entirety by the risk factors and cautionary statements included in this Annual Report. Except as is required by law, we expressly disclaim any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this Annual Report.
Trademarks and Trade Names
All trademarks or trade names referred to in this Annual Report on Form 10-K are the property of the company, or, to the extent trademarks or trade names belonging to other companies are referenced in this Annual Report on Form 10-K, the property of their respective owners. Solely for convenience, the trademarks and trade names in this Annual Report on Form 10-K are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company’s or their rights thereto. We do not intend the use or display of other companies’ trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
4
Part I
Item 1.
Business
Eli Lilly and Company (referred to as the company, Lilly, we, or us) was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in